Skin topical composition

The combination of retinol and camellia seed oil in a skin care composition addresses the need for enhanced hyaluronic acid production and skin cell proliferation, resulting in improved wrinkle reduction and skin quality.

JP7577429B2Active Publication Date: 2024-11-05SUNSTAR INC
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2018240949
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-12-27
Filing Date
2018-12-25
Publication Date
2024-11-05
Estimated Expiration
2038-12-25

AI Technical Summary

Technical Problem

Existing anti-wrinkle skin care compositions do not effectively enhance hyaluronic acid production and collagen synthesis, which are crucial for reducing wrinkles and improving skin quality.

Method used

A composition combining retinol with camellia seed oil, specifically formulated to enhance the expression of hyaluronic acid synthase genes (HAS2 and/or HAS3) and cell growth factor genes (HB-EGF) to promote hyaluronic acid production and skin cell proliferation.

Benefits of technology

The composition significantly enhances hyaluronic acid production and skin cell proliferation, providing effective wrinkle prevention and improvement, as well as skin beautification and quality enhancement.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007577429000002
    Figure 0007577429000002
  • Figure 0007577429000003
    Figure 0007577429000003
  • Figure 0007577429000004
    Figure 0007577429000004
Patent Text Reader

Abstract

To provide an anti-wrinkle skin composition for external use exhibiting excellent anti-wrinkling effects.SOLUTION: There is provided a skin composition for external use comprising retinol and camellia seed oil.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a composition for external use on the skin.

[0002] As the skin ages, wrinkles increase. Wrinkles can range from thin, horizontal lines under the eyes that run horizontally and are at the epidermis level (epidermal wrinkles), to fine lines that run perpendicular to the direction of facial muscles at the corners of the eyes and on the forehead and are at the dermis level (dermal wrinkles), and large lines around the eyes, mouth, and facial contours (senile wrinkles). Research is being conducted to find a solution that acts comprehensively on the epidermis, dermis, and other areas to prevent and improve wrinkles in a multifaceted way.

[0003] Retinol and its derivatives are a type of vitamin known to be involved in maintaining biological functions such as vision and in the regeneration of normal epithelial tissues such as the skin and mucous membranes. They are known as topical medications for abnormal keratinization skin diseases such as ichthyosis vulgaris. Retinol derivatives are also known to inhibit skin aging by maintaining the activity of epithelial tissue and blocking the transmission of ultraviolet light signals, and are therefore widely used in cosmetics to prevent skin aging.

[0004] Furthermore, it has been found that a substance in which retinol is bound via succinic acid to a polypeptide (poly(proline-hydroxyproline-glycine)) obtained by condensing peptide units having a specific amino acid sequence has low cytotoxicity, increases hyaluronic acid production in the epidermis, and promotes collagen synthesis in the dermis (Patent Document 1). [Prior art documents] [Patent documents]

[0005] [Patent Document 1] International Publication No. 2011 / 158864 DISCLOSURE OF THEINVENTION [Problem to be solved by the invention]

[0006] An object of the present invention is to provide an anti-wrinkle skin composition for external use that exhibits excellent anti-wrinkle effects (e.g., wrinkle formation prevention effect, wrinkle improvement effect, skin beautifying effect, skin quality improvement effect, etc.). [Means for solving the problem]

[0007] The present inventors discovered that a significantly higher effect of enhancing the expression of the HAS2 and / or HAS3 genes can be obtained by combining retinol with oil obtained from camellia seeds (camellia seed oil), and through further improvements, have completed the present invention.

[0008] The present invention encompasses, for example, the subject matter described in the following paragraphs. Section 1. A skin topical composition comprising retinol and camellia seed oil. Section 2. Item 2. The composition according to item 1, wherein the fatty acid content ratio of camellia seed oil is as follows: Palmitic acid: 7.5-20.0% Oleic acid: 62.0-85.0% Linoleic acid: 3.5-10.0% Linolenic acid: 1.5% or less Stearic acid: 0.5-5.0% Section 3. Item 3. The composition according to item 1 or 2, which is an anti-wrinkle skin topical composition. Section 4. Item 4. The composition according to any one of Items 1 to 3, which is a composition for enhancing hyaluronic acid production by epidermal cells. Section 5. A method for imparting or enhancing an anti-wrinkle effect to a composition for external use on the skin when the composition is applied to the skin by adding retinol and camellia seed oil to the composition. Section 6. A method for enhancing the anti-wrinkle effect of retinol when applied to the skin by adding retinol and camellia seed oil to a composition for external use on the skin. Effect of the Invention

[0009] By using the topical skin composition of the present invention, excellent anti-wrinkle effects (more specifically, for example, wrinkle formation prevention effects, wrinkle improvement effects, skin beautifying effects, skin quality improvement effects, etc.) can be obtained. [Brief description of the drawings]

[0010] [Figure 1] The effect of retinol (10-5M) and / or camellia seed oil (0.001% or 0.005%) on the expression of hyaluronic acid synthase gene (HAS2) was analyzed by real-time PCR. [Diagram 2] The results of analyzing the effect of retinol (0.05%) and / or camellia seed oil (1% or 2%) on the expression of hyaluronan synthase gene (HAS3) in a three-dimensional skin model by real-time PCR are shown. [Diagram 3] The results of a real-time PCR analysis of the effects of retinol (0.05%) and / or camellia seed oil (2%, 3%, or 5%) on the expression of a gene involved in cell proliferation (HB-EGF) in a three-dimensional skin model are shown. [Figure 4] The results of an analysis of the effects of retinol (0.05%) and / or camellia seed oil (1%, 2%, or 3%) on hyaluronic acid synthesis in a three-dimensional skin model by quantifying the amount of hyaluronic acid are shown. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011] Each embodiment of the present invention will now be described in further detail.

[0012] The topical skin composition encompassed by the present invention contains retinol and camellia seed oil, and hereinafter, this composition may be referred to as the topical skin composition of the present invention.

[0013] Retinol is a compound represented by the following structural formula, and as mentioned above, is used in cosmetics for preventing skin aging.

[0014] [ka]

[0015] The content of retinol in the composition for external use on the skin of the present invention is not particularly limited as long as the effect of the present invention is not impaired, but is preferably, for example, about 0.005 to 1% by mass, about 0.01 to 0.5% by mass, or about 0.02 to 0.1% by mass. -6 ~10 -2 It is preferable that the thickness is about 10 -5 ~10 -2.5 It is more preferable that the thickness is about M.

[0016] The camellia seed oil used in the present invention is an oil obtained by extraction from camellia seeds. There is no particular limitation on the camellia as long as it is a plant belonging to the genus Camellia in the family Theaceae and the seed oil thereof can obtain the effects of the present invention. Among them, Camellia Japonica is preferable. There is no particular limitation on the method for extracting oil from camellia seeds, and known methods or methods easily conceived from known methods can be used. For example, a pressing method or a boiling method can be used. In addition, a commercially available product can be purchased as the camellia seed oil.

[0017] Camellia seed oil contains various fatty acids. The following fatty acid content ratios are more preferable for use in the present invention: palmitic acid: 7.5-20.0%, oleic acid: 62.0-85.0%, linoleic acid: 3.5-10.0%, linolenic acid: 1.5% or less, stearic acid: 0.5-5.0%.

[0018] The content of camellia seed oil contained in the skin external composition of the present invention is not particularly limited as long as it is within a range in which the effects of the present invention can be obtained, but for example, it is preferably about 0.0005 to 10 mass%, more preferably about 0.001 to 5 mass%, even more preferably about 0.01 to 2 mass%, and even more preferably about 0.1 to 2 mass%. The upper limit of the range may be about 0.5, 0.05, 0.01 mass% or 0.005 mass%.

[0019] The skin topical composition of the present invention may further contain known components used in skin topical compositions (particularly topical pharmaceutical compositions and cosmetic compositions). Examples of such components include water, oils, surfactants, moisturizers, higher alcohols, sequestering agents, natural and synthetic polymers, water-soluble and oil-soluble polymers, UV screening agents, various extracts, colorants such as organic dyes, preservatives, antioxidants, pigments, thickeners, pH adjusters, fragrances, cooling agents, antiperspirants, bactericides, skin activators, and various powders. The amounts of these components can also be appropriately set based on information on the amounts of these components that are known to be used in skin topical compositions. Although not particularly limited, the amount may be, for example, about 1 to 99.9% by mass, or about 50 to 99.9% by mass.

[0020] Although not particularly limited, the skin external composition of the present invention is preferably a liquid composition. Examples of the usage form of the skin external composition of the present invention include face packs, pastes, ointments, creams, gels, lotions, milky lotions, beauty essences, skin lotions, sprays, hair care products, etc.

[0021] The skin topical composition of the present invention can be produced by a known method or a method easily derived from a known method, for example, by appropriately mixing retinol, camellia seed oil, and other known ingredients used in skin topical compositions.

[0022] In addition, the skin topical composition of the present invention contains retinol and camellia seed oil, and thus has an excellent effect of enhancing the expression of hyaluronic acid synthase genes (particularly HAS2 and / or HAS3) and / or cell growth factor genes (particularly HB-EGF gene) in the skin (particularly epidermal cells).In addition, the skin topical composition of the present invention has an excellent effect of enhancing the production of hyaluronic acid in the skin (particularly epidermal cells).

[0023] Hyaluronan synthase (HAS) is an enzyme that synthesizes hyaluronic acid, and HAS2 and HAS3 are types of HAS. Increased expression of HAS promotes hyaluronic acid synthesis, which favorably exerts an anti-wrinkle effect. It is also known that heparin-binding EGF-like growth factor (HB-EGF) is involved in skin cell proliferation, and that an increase in HB-EGF in particular accelerates skin turnover and regenerates new skin. This can eliminate trauma, sunburn, wrinkles, and blemishes.

[0024] Therefore, the present invention also includes a composition for enhancing hyaluronic acid synthesis (or production) containing retinol and camellia seed oil, and a composition for promoting cell (particularly skin cells, particularly epidermal cells) proliferation or skin turnover containing retinol and camellia seed oil. The above description is preferably applied to each component contained in these compositions.

[0025] The present invention also preferably encompasses (i) a method for imparting or enhancing an anti-wrinkle effect to a composition for topical skin when applied to the skin by including retinol and camellia seed oil in the composition, and (ii) a method for enhancing the anti-wrinkle effect of retinol when applied to the skin by including retinol and camellia seed oil in a composition for topical skin.

[0026] In method (i), the anti-wrinkle effect of the composition itself when applied to the skin is enhanced by incorporating a combination of specific ingredients, retinol and camellia seed oil, in the composition for external use on the skin, or when the composition itself does not contain any ingredients other than retinol and camellia seed oil that exert an anti-wrinkle effect when applied to the skin, said effect can be imparted. In method (ii), retinol itself is originally expected to have an anti-wrinkle effect when applied to the skin, and by using camellia seed oil in combination with retinol (i.e., by incorporating retinol and camellia seed oil in the topical skin preparation), the anti-wrinkle effect of retinol can be enhanced.

[0027] It should be noted that in this specification, the term "comprising" encompasses "consisting essentially of" and "consisting of." EXAMPLES

[0028] The present invention will be described in more detail below, but the present invention is not limited to the following examples. In the following, unless otherwise specified, % indicating the content ratio of each component in various compositions used in the following studies represents mass (w / w) %. % of CO2 concentration is v / v %. The fatty acid content ratio of the camellia seed oil used satisfied the following ranges: palmitic acid: 7.5-20.0%, oleic acid: 62.0-85.0%, linoleic acid: 3.5-10.0%, linolenic acid: 1.5% or less, stearic acid: 0.5-5.0%.

[0029] Expression study of hyaluronic acid synthesis enzyme genes and cell proliferation promoting genes Using NHEK cells (normal human epidermal keratinocytes; derived from newborns), we investigated whether retinol and camellia seed oil would affect the expression of hyaluronic acid synthase gene (HAS2) and cell proliferation promoting gene (HB-EGF).All cells, media, and media-related reagents were purchased from commercial sources (Kuraray Industries, Inc. or Sigma-Aldrich).

[0030] <Growth medium preparation method> 0.5 ml of insulin, 0.5 ml of hEGF, 0.5 ml of hydrocortisol, 2 ml of BPE (bovine pituitary extract), and 0.5 ml of gentamicin / amphotericin B (antibacterial agents) were added to 500 ml of HuMedia-KB2 medium incubated at 37°C. The mixture was gently mixed and then stored at 4°C.

[0031] <Method of thawing frozen NHEK cells and replacing the medium> Two ampoules containing frozen NHEK cells were thawed in a 37°C thermostat. After thawing, the cell solution was mixed with 6 ml of 4°C Humedia-KG2 medium previously dispensed into a 15 ml tube. 39 ml of Humedia-KG2 medium pre-warmed to 37°C was transferred to three flasks, 13 ml each. The mixed cell solution was transferred to an adherent cell culture flask (SUMILON 250 mL), 2 ml at a time, mixed to make the cells uniform, and then allowed to stand for a while. It was cultured in a 37°C, 5% CO2 incubator. From the next day onwards, the medium was changed once a day until the cell density reached 80% confluence.

[0032] <Subculture method of NHEK cells> The growth medium was aspirated, 5 mL of HEPES buffer pre-warmed to 37°C was added, and the cell layer was gently washed. The HEPES buffer was aspirated, 2 mL of 0.25% trypsin solution was added, and it was left standing in a 37°C, 5% CO2 incubator for 3 minutes. Then, the cells adhering to the bottom of the flask were detached (gently tapping the edge of the flask to detach the cells). 4 mL of trypsin neutralizing solution pre-warmed to 37°C was added thereto to stop the reaction of the trypsin enzyme. The cell suspension was collected in a 50 ml Falcon tube and centrifuged (RT, 1,000 rpm, 5 min). The supernatant was aspirated, mixed with 10 ml of Humedia-KG2 medium, and then the cell count was measured using a hemocytometer. Then, 950 μL of the medium and 1.2×10 5 cells were seeded into an adherent cell 24-well plate. The next day, the medium was changed.

[0033] <Sample addition method> The growth medium was aspirated, washed with 1 ml of PBS, and then a test sample (retinol and / or camellia seed oil) mixed with 1 ml of Humedia-KB2 medium was added and cultured for 24 hours. Note that retinol was 10 -5It was added to the medium so as to obtain the final concentration of M. Camellia seed oil was added to the medium so as to obtain a final concentration of 0.001% or 0.005% during the expression analysis of the HAS2 gene, and was added to the medium so as to obtain a final concentration of 0.1% by mass during the expression analysis of the HB-EGF gene. In addition, a solution obtained by adding DMSO (dimethyl sulfoxide) diluted to 1 / 1000 in volume in the medium instead of retinol was also cultured for 24 hours in the same manner.

[0034] <Cell recovery method> Humedia-KB2 medium was aspirated and washed with 1 ml of PBS. PBS was aspirated, 350 μl of RLT (cell lysate) was added, and the mixture was shaken on a plate shaker for 3 min. The periphery of the 24-well plate was covered with vinyl tape and stored at -80°C.

[0035] <Preparation of cDNA> The 24-well plate was taken out from -80°C and thawed in a thermostatic bath. 350 μl of 70% EtOH was added, and the mixture was shaken on a plate shaker for 3 minutes. Total RNA samples were extracted using the RNeasy Mini Kit (Qiagen). The RNA concentration was measured with a NANODROP 2000 Spectrophotometer (Thermo SCIENTIFIC), and cDNA was prepared from approximately 500 ng of total RNA using the PrimeScript RT reagent Kit (Takara Bio Inc.).

[0036] <Real-time PCR> Primer, ROX DyeII and RNA Free water were added to 10 μl of Primix Ex Taq (Takara Bio Inc.) to prepare an 18 μl mixture, and 2 μl (about 50 ng) of cDNA sample was added to prepare a Real-Time PCR measurement sample for each primer. β-actin was selected as the endogenous control, and HAS2 and HB-EGF were selected as the target genes. Expression analysis (relative quantification) of the target genes was performed by the calibration curve method using a Real-Time PCR Standard 7500 (Applied Biosystems).

[0037] The results of the HAS2 gene expression analysis (gene expression ratio when DMSO was added is set to 1) are shown in Figure 1. In Figure 1, *** indicates that there is a significant difference (***: P<0.001). In the figure, *** at the top of the bar graph indicates that there is a significant difference compared to the control (DMSO added), and *** at the top of the horizontal bar indicates that there is a significant difference when comparing the samples located at the ends of the horizontal bar. In addition, as a result of the HB-EGF gene analysis, the gene expression ratio when DMSO was added was set to 1 was approximately 6.4 when only retinol was added, and approximately 9.9 when retinol and camellia seed oil were added, which was significantly higher when retinol and camellia seed oil were added than when only retinol was added (P<0.05).

[0038] Examination of hyaluronic acid synthesis and cell proliferation promoting gene expression using a three-dimensional skin model Using a three-dimensional skin model, we investigated whether retinol and camellia seed oil would affect the expression of hyaluronic acid synthase gene (HAS3) and cell proliferation promoting gene (HB-EGF). We also investigated whether they would affect the expression of the final product, hyaluronic acid production. All cells, media, and media-related reagents were purchased from commercial sources (MatTek, Kurashiki Boseki Co., Ltd., or Sigma-Aldrich).

[0039] <Cultivation method for three-dimensional skin model> A three-dimensional skin model was cultured using a kit (EPI-200) from MatTek. Specifically, 500 μl of Assay medium, which had been thermostated at 37°C, was added to each 24-well plate, and a three-dimensional skin model consisting of NHEK cells (normal human epidermal keratinocytes; derived from a newborn) prepared by MatTek was placed on top. The model was cultured for one day in a 5% CO2 incubator at 37°C.

[0040] <Sample addition method> 50μl of the test sample (retinol and / or camellia seed oil) was added to the three-dimensional skin model and cultured for 24 hours (gene expression analysis experiment by real-time PCR) or 48 hours (quantitative experiment of hyaluronic acid production) (the test sample was added so that it was evenly soaked in the entire skin). Retinol was adjusted to a concentration of 0.05% before being added to the three-dimensional skin model. Camellia seed oil was adjusted to a concentration of 1% or 2% before being added to the three-dimensional skin model for the expression analysis of the HAS3 gene, adjusted to a concentration of 2%, 3%, or 5% before being added to the three-dimensional skin model for the expression analysis of the HB-EGF gene, and adjusted to a concentration of 1%, 2%, or 3% before being added to the three-dimensional skin model for the quantitative experiment of hyaluronic acid production. The three-dimensional skin model was also cultured for 24 or 48 hours under additive-free conditions.

[0041] The concentration of the retinol solution to be added was adjusted by first preparing a concentrated solution in which retinol was dissolved in a mixture of Decaglyn 1-L, 1,3-BG, and ion-exchanged water to a concentration of 1%, and then diluting this with ion-exchanged water.The concentration of the camellia seed oil to be added was adjusted by first preparing a concentrated solution in which camellia seed oil was dissolved in a mixture of Decaglyn 1-L, 1,3-BG, and ion-exchanged water to a concentration of 20%, and then diluting this with ion-exchanged water.

[0042] <How to collect the 3D skin model> 500μL of PBS was added to a new 24-well plate, and the three-dimensional skin model was transferred thereto. The liquid remaining on the skin was gently aspirated with an aspirator and washed with PBS. The three-dimensional skin model was separated from the cup with tweezers, and the membrane was peeled off using tweezers as well. The peeled three-dimensional skin model was placed in a heat-resistant tube, frozen with liquid nitrogen, and then stored at -80℃.

[0043] <RNA extraction from three-dimensional skin model and cDNA preparation> 600μL of RLT (cell lysis solution) was added to a 15mL Falcon plastic tube and cooled on ice. Frozen samples stored at -80℃ were cooled with liquid nitrogen, then placed in RLT and homogenized for 40 seconds using a homogenizer POLYTRON (KINEMATICA). The three-dimensional skin model disrupted solution was collected in a 1.5mL tube and centrifuged (RT, 14,000rpm, 5min). The supernatant was collected, and an equal volume of 70% EtOH (350μl) was added and mixed with a vortex. Total RNA samples were extracted using RNeasy Mini Kit (Qiagen). RNA concentration was measured using a NANODROP 2000 Spectriphotometer (Thermo SCIENTIFIC), and cDNA was prepared from approximately 500ng of total RNA using PrimeScript RT reagent Kit (Takara Bio).

[0044] <Real-time PCR> Real-time PCR was performed in the same manner as above. That is, primers, ROX DyeII and RNA-free water were added to 10 μl of Primix Ex Taq (Takara Bio), and about 50 ng of cDNA sample was added to the mixture to prepare 20 μl of Real-Time PCR measurement samples for each primer. β-actin was selected as an endogenous control, and HAS3 and HB-EGF were selected as target genes. Expression analysis of the target genes (relative quantification) was performed by the standard curve method using Real-Time PCR Standard7500 (Applied Biosystems).

[0045] The results of the HAS3 gene expression analysis (gene expression ratio when the control (no addition) is set to 1) are shown in FIG. 2. The results of the HB-EGF gene analysis (gene expression ratio when the control (no addition) is set to 1) are shown in FIG. 3. In FIG. 2 and FIG. 3, ***, **, *, and + indicate significant differences (***: P<0.001, **: P<0.01, *: P<0.05, +: P<0.1). These symbols at the top of the bar graphs indicate significant differences compared to the control (no addition). These symbols at the top of the horizontal bars indicate significant differences when comparing the samples located at the ends of the horizontal bars. In FIG. 2, the symbols at the top of the bar graphs showing the results when only camellia seed oil was added ("1% camellia oil" and "2% camellia oil") indicate significant differences in terms of reduction compared to the control (no addition).

[0046] <Extraction of hyaluronic acid from three-dimensional skin models> Frozen samples (three-dimensional skin models) stored at -80°C were freeze-dried for 3 hours using a freeze dryer FDU-2200 (Tokyo Rikakikai Co., Ltd.), and the dry weight was measured. 1 ml of 2.5% Actinase E (Kaken Pharmaceutical Co., Ltd.) / 10 mM Tris-HCl (pH 8.0) solution was added per 10 mg of dry weight, and the mixture was reacted at 55°C for 24 hours in a heat block to perform proteolysis. The mixture was reacted at 100°C for 10 minutes in a heat block, and the actinase was boiled and inactivated. The mixture was then centrifuged (RT, 12,000 rpm, 10 min) and the supernatant was collected.

[0047] <Quantitative analysis of hyaluronic acid production> The amount of hyaluronic acid in the obtained supernatant was quantified using a Hyaluronan Quantikine ELISA Kit (Funakoshi). The results are shown in Figure 4. In Figure 4, *** and * indicate significant differences (***: P<0.001, *: P<0.05). *** and * above the bars indicate significant differences between the samples located at the ends of the bars.

[0048] The base sequences of the primers used in each PCR are as follows: (F: indicates the forward primer, and R: indicates the reverse primer.) β-actin F:TTGTTACAGGAAGTCCCTTGCC R:ATGCTATCACCTCCCCTGTGTG HAS2 F: AGTCATGTACACAGCCTTCAGAGCA R: CACCTCCAACCATGGGATCTC HAS3 F:TCGGCGATTCGGTGGACTA R:CCTCCAGGACTCGAAGCATCTC HB-EGF F: GGGACCCATGTCTTCGGAAATA R:CCAGGATGGTTGTGTGTGGTCATAG

Claims

1. A skin topical composition comprising retinol and camellia seed oil, The retinol content is 0.01 to 0.5% by mass, The content of camellia seed oil is 0.1 to 10% by mass, and A skin external composition for enhancing hyaluronic acid production by epidermal cells, comprising retinol and camellia seed oil in a mass ratio of 1:25-100.

2. 2. The composition of claim 1, wherein the fatty acid content of the camellia seed oil is as follows: Palmitic acid: 7.5-20.0% Oleic acid: 62.0-85.0% Linoleic acid: 3.5-10.0% Linolenic acid: 1.5% or less Stearic acid: 0.5-5.0%

3. The composition according to claim 1 or 2, which is an anti-wrinkle skin composition for external use.

4. The skin topical composition contains retinol and camellia seed oil. The retinol content is 0.01 to 0.5% by mass, The content of camellia seed oil is 0.1 to 10% by mass, and A method for imparting or enhancing an anti-wrinkle effect by enhancing the production of hyaluronic acid in epidermal cells when the composition is applied to the skin, by containing retinol and camellia seed oil in a mass content ratio of 1:25 to 100.

5. The skin topical composition contains retinol and camellia seed oil. The retinol content is 0.01 to 0.5% by mass, The content of camellia seed oil is 0.1 to 10% by mass, and A method for enhancing the anti-wrinkle effect of retinol when applied to the skin by incorporating retinol and camellia seed oil in a mass content ratio of 1:25 to 100, comprising: The method, wherein the anti-wrinkle effect is an anti-wrinkle effect due to enhanced production of hyaluronic acid by epidermal cells.

Citation Information

Patent Citations

  • Skin cosmetic and application thereof

    JP2007077172A

  • Retinol-modified collagen, method for producing same, and external composition for skin containing same

    WO2011158864A1